Disseminated Rhizopus microsporus infection in a patient on oral corticosteroid treatment: a case report

被引:0
作者
de Mol, P. [1 ]
Meis, J. F. G. M. [2 ]
机构
[1] Canisius Wilhelmina Hosp, Dept Internal Med, Nijmegen, Netherlands
[2] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands
关键词
Corticosteroids; disseminated zygomycosis; non-neutropenic; Rhizopus microsporus var. microsporus; ZYGOMYCOSIS; MUCORMYCOSIS; DIAGNOSIS; POSACONAZOLE; THERAPY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 71-year-old male with mild steroid-induced hyperglycaemia was diagnosed with a lethal invasive Rhizopus microsporus infection. Disseminated zygomycosis is a rare entity and is most frequently found in neutropenic patients with haematological malignancies, post-transplants or in patients on deferoxamine therapy. Infection is characterised by tissue infarction and necrosis due to angioinvasive hyphae. Culture of Zygomycetes is necessary for species determination but histology is a must to prove the infection. Ante-mortem diagnosis and culture is challenging and therefore mortality approaches 100%. Apart from amphotericine B, most anti-fungals have no activity against Zygomycetes but posaconazole might offer new possibilities as a first-line agent. Timely diagnosis, rapid surgery of infected tissue, correction of underlying disorders and correct anti-fungal therapy might be life-saving. Due to the increasing use of potent immunosuppression, stem cell and organ transplants and possibly selection for Zygomycetes by prior treatment with broad-spectrum antifungal therapy, the incidence of zygomycosis is rising. Therefore, clinicians might encounter an increasing number of zygomycosis cases in the near future.
引用
收藏
页码:25 / 28
页数:4
相关论文
共 20 条
[1]   Zygomycosis: the re-emerging fungal infection [J].
Chayakulkeeree, M. ;
Ghannoum, M. A. ;
Perfect, J. R. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2006, 25 (04) :215-229
[2]   Activity of posaconazole in treatment of experimental disseminated zygomycosis [J].
Dannaoui, E ;
Meis, JFGM ;
Loebenberg, D ;
Verweij, PE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (11) :3647-3650
[3]   In vitro susceptibilities of zygomycetes to conventional and new antifungals [J].
Dannaoui, E ;
Meletiadis, J ;
Mouton, JW ;
Meis, JFGM ;
Verweij, PE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (01) :45-52
[4]  
Eucker J, 2001, MYCOSES, V44, P253, DOI 10.1111/j.1439-0507.2001.00656.x
[5]   The role of BAL in the diagnosis of pulmonary mucormycosis [J].
Glazer, M ;
Nusair, S ;
Breuer, R ;
Lafair, J ;
Sherman, Y ;
Berkman, N .
CHEST, 2000, 117 (01) :279-282
[6]   Posaconazole as salvage therapy for zygomycosis [J].
Greenberg, RN ;
Mullane, K ;
van Burik, JAH ;
Raad, I ;
Abzug, MJ ;
Anstead, G ;
Herbrecht, R ;
Langston, A ;
Marr, KA ;
Schiller, G ;
Schuster, M ;
Wingard, JR ;
Gonzalez, CE ;
Revankar, SG ;
Corcoran, G ;
Kryscio, RJ ;
Hare, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :126-133
[7]   Zygomycosis (mucormycosis): emerging clinical importance and new treatments [J].
Greenberg, RN ;
Scott, LJ ;
Vaughn, HH ;
Ribes, JA .
CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (06) :517-525
[8]   ZYGOMYCOSIS REQUIRING AMPUTATION OF THE HAND - AN ISOLATED CASE IN A PATIENT RECEIVING HEMODIALYSIS [J].
KERR, PG ;
TURNER, H ;
DAVIDSON, A ;
BENNETT, C ;
MASLEN, M .
MEDICAL JOURNAL OF AUSTRALIA, 1988, 148 (05) :258-259
[9]  
Kobayashi M, 2001, MYCOSES, V44, P311, DOI 10.1111/j.1439-0507.2001.00642.x
[10]   Zygomycosis in a Tertiary-Care Cancer Center in the era of Aspergillus-active antifungal therapy:: A case-control observational study of 27 recent cases [J].
Kontoyiannis, DP ;
Lionakis, MS ;
Lewis, RE ;
Chamilos, G ;
Healy, M ;
Perego, C ;
Safdar, A ;
Kantarjian, H ;
Champlin, R ;
Walsh, TJ ;
Raad, II .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (08) :1350-1360